mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.003 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.003 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.004 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.004 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.005 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.005 |